Abstract
Using the protein-protein interaction of Mcl-1/Noxa, two methods for efficient modulator discovery are directly compared. In silico peptide-directed ligand design is evaluated against experimental peptide-directed, allowing for the discovery of two new inhibitors of Mcl-1/Noxa with cellular activity. In silico peptide-directed ligand design demonstrates an in vitro hit rate of 80%. The two rapid and efficient methods demonstrate complementary features for protein-protein interaction modulator discovery.
Supplementary materials
Title
Howell & Beekman - Preprint - SI
Description
Actions